{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:17:14Z","timestamp":1790752634708,"version":"4.1.0"},"reference-count":268,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"am","delay-in-days":294,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.bcp.2024.116468","type":"journal-article","created":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T06:02:56Z","timestamp":1722837776000},"page":"116468","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["ABC transporters involved in respiratory and cholestatic diseases: From rare to very rare monogenic diseases"],"prefix":"10.1016","volume":"229","author":[{"given":"Mounia","family":"Lakli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Onn\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Carrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Becq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Falgui\u00e8res","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Fanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2\u20133","key":"10.1016\/j.bcp.2024.116468_b0005","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.mam.2012.12.009","article-title":"The ABCs of membrane transporters in health and disease (SLC series): introduction","volume":"34","author":"Hediger","year":"2013","journal-title":"Mol Aspects Med."},{"issue":"6","key":"10.1016\/j.bcp.2024.116468_b0010","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nsmb.3216","article-title":"Mechanistic diversity in ATP-binding cassette (ABC) transporters","volume":"23","author":"Locher","year":"2016","journal-title":"Nat Struct Mol Biol."},{"issue":"7","key":"10.1016\/j.bcp.2024.116468_b0015","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1101\/gr.184901","article-title":"The Human ATP-Binding Cassette (ABC) Transporter Superfamily","volume":"11","author":"Dean","year":"2001","journal-title":"Genome Res."},{"issue":"13","key":"10.1016\/j.bcp.2024.116468_b0020","doi-asserted-by":"crossref","first-page":"6711","DOI":"10.3390\/ijms22136711","article-title":"The Role of ABC Transporters in Lipid Metabolism and the Comorbid Course of Chronic Obstructive Pulmonary Disease and Atherosclerosis","volume":"22","author":"Kotlyarov","year":"2021","journal-title":"Int J Mol Sci."},{"issue":"11","key":"10.1016\/j.bcp.2024.116468_b0025","doi-asserted-by":"crossref","first-page":"6093","DOI":"10.3390\/ijms22116093","article-title":"Peroxisomal ABC Transporters: An Update","volume":"22","author":"Tawbeh","year":"2021","journal-title":"Int J Mol Sci."},{"issue":"1","key":"10.1016\/j.bcp.2024.116468_b0030","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1023\/B:JOBB.0000019593.84933.e6","article-title":"Insights into ABC transport in archaea","volume":"36","author":"Albers","year":"2004","journal-title":"J Bioenerg Biomembr."},{"key":"10.1016\/j.bcp.2024.116468_b0035","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1146\/annurev.biochem.73.011303.073626","article-title":"ATP-binding cassette transporters in bacteria","volume":"73","author":"Davidson","year":"2004","journal-title":"Annu Rev Biochem."},{"issue":"1","key":"10.1016\/j.bcp.2024.116468_b0040","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1042\/BST20180147","article-title":"Learning the ABCs one at a time: structure and mechanism of ABC transporters","volume":"47","author":"Ford","year":"2019","journal-title":"Biochem Soc Trans."},{"issue":"4","key":"10.1016\/j.bcp.2024.116468_b0045","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/brv.12702","article-title":"ATP binding cassette importers in eukaryotic organisms","volume":"96","author":"Choi","year":"2021","journal-title":"Biol Rev Camb Philos Soc."},{"issue":"4","key":"10.1016\/j.bcp.2024.116468_b0050","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1085\/jgp.201411164","article-title":"Structural diversity of ABC transporters","volume":"143","author":"ter Beek","year":"2014","journal-title":"J Gen Physiol."},{"issue":"5","key":"10.1016\/j.bcp.2024.116468_b0055","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1042\/BST20150047","article-title":"Structural basis for the mechanism of ABC transporters","volume":"43","author":"Beis","year":"2015","journal-title":"Biochem Soc Trans."},{"key":"10.1016\/j.bcp.2024.116468_b0060","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0076-6879(98)92012-2","article-title":"Saccharomyces cerevisiae ABC proteins and their relevance to human health and disease","volume":"292","author":"Taglicht","year":"1998","journal-title":"Methods Enzymol."},{"issue":"9","key":"10.1016\/j.bcp.2024.116468_b0065","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1002\/humu.24418","article-title":"The human ATP-binding cassette (ABC) transporter superfamily","volume":"43","author":"Dean","year":"2022","journal-title":"Hum Mutat."},{"issue":"23","key":"10.1016\/j.bcp.2024.116468_b0070","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1002\/1873-3468.13935","article-title":"Structural and functional diversity calls for a new classification of ABC transporters","volume":"594","author":"Thomas","year":"2020","journal-title":"FEBS Lett."},{"issue":"3","key":"10.1016\/j.bcp.2024.116468_b0075","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/nrm2646","article-title":"ABC transporters: the power to change","volume":"10","author":"Rees","year":"2009","journal-title":"Nat Rev Mol Cell Biol."},{"issue":"50","key":"10.1016\/j.bcp.2024.116468_b0080","first-page":"43","article-title":"Structure of ABC transporters","volume":"7","author":"Zolnerciks","year":"2011","journal-title":"Essays Biochem."},{"key":"10.1016\/j.bcp.2024.116468_b0085","article-title":"Structure and mechanism of ABC transporters","author":"Wilkens","year":"2015714","journal-title":"F1000prime Rep."},{"issue":"9","key":"10.1016\/j.bcp.2024.116468_b0090","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1517\/17425250903124371","article-title":"Oligomerization of human ATP-binding cassette transporters and its potential significance in human disease","volume":"5","author":"Mo","year":"2009","journal-title":"Expert Opin Drug Metab Toxicol."},{"issue":"7","key":"10.1016\/j.bcp.2024.116468_b0095","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.3390\/ijms18071593","article-title":"Predictive Structure and Topology of Peroxisomal ATP-Binding Cassette (ABC) Transporters","volume":"18","author":"Andreoletti","year":"2017","journal-title":"Int J Mol Sci."},{"issue":"Pt 3","key":"10.1016\/j.bcp.2024.116468_b0100","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1042\/bj20030683","article-title":"Dimeric cystic fibrosis transmembrane conductance regulator exists in the plasma membrane","volume":"374","author":"Ramjeesingh","year":"2003","journal-title":"Biochem J."},{"issue":"29","key":"10.1016\/j.bcp.2024.116468_b0105","doi-asserted-by":"crossref","first-page":"20283","DOI":"10.1074\/jbc.M601072200","article-title":"Transition from Dimers to Higher Oligomeric Forms Occurs during the ATPase Cycle of the ABCA1 Transporter","volume":"281","author":"Trompier","year":"2006","journal-title":"J Biol Chem."},{"issue":"12","key":"10.1016\/j.bcp.2024.116468_b0110","doi-asserted-by":"crossref","first-page":"8821","DOI":"10.1074\/jbc.M700152200","article-title":"Regulation of function by dimerization through the amino-terminal membrane-spanning domain of human ABCC1\/MRP1","volume":"282","author":"Yang","year":"2007","journal-title":"J Biol Chem."},{"issue":"2","key":"10.1016\/j.bcp.2024.116468_b0115","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1021\/pr201003g","article-title":"Human ABCC1 Interacts and Colocalizes with ATP Synthase \u03b1, Revealed by Interactive Proteomics Analysis","volume":"11","author":"Yang","year":"2012","journal-title":"J Proteome Res."},{"issue":"2","key":"10.1016\/j.bcp.2024.116468_b0120","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3892\/ijmm.2016.2650","article-title":"Homooligomerization of ABCA3 and its functional significance","volume":"38","author":"Frixel","year":"2016","journal-title":"Int J Mol Med."},{"issue":"1","key":"10.1016\/j.bcp.2024.116468_b0125","doi-asserted-by":"crossref","first-page":"15662","DOI":"10.1038\/s41598-018-33841-w","article-title":"Structural and functional insights into the interaction and targeting hub TMD0 of the polypeptide transporter TAPL","volume":"8","author":"Bock","year":"2018","journal-title":"Sci Rep."},{"issue":"1","key":"10.1016\/j.bcp.2024.116468_b0130","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.canlet.2015.10.010","article-title":"Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade","volume":"370","author":"Chen","year":"2016","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.bcp.2024.116468_b0135","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.febslet.2005.11.079","article-title":"ABC transporter architecture and regulatory roles of accessory domains","volume":"580","author":"Biemans-Oldehinkel","year":"2006","journal-title":"FEBS Lett."},{"issue":"5","key":"10.1016\/j.bcp.2024.116468_b0140","doi-asserted-by":"crossref","first-page":"16724","DOI":"10.1038\/srep16724","article-title":"Tracing the structural evolution of eukaryotic ATP binding cassette transporter superfamily","volume":"18","author":"Xiong","year":"2015","journal-title":"Sci Rep."},{"issue":"12","key":"10.1016\/j.bcp.2024.116468_b0145","doi-asserted-by":"crossref","first-page":"L970","DOI":"10.1152\/ajplung.00184.2013","article-title":"Disruption of N-linked glycosylation promotes proteasomal degradation of the human ATP-binding cassette transporter ABCA3","volume":"305","author":"Beers","year":"2013","journal-title":"Am J Physiol-Lung Cell Mol Physiol."},{"issue":"26","key":"10.1016\/j.bcp.2024.116468_b0150","doi-asserted-by":"crossref","first-page":"23539","DOI":"10.1074\/jbc.M101902200","article-title":"Membrane topology of the ATP binding cassette transporter ABCR and its relationship to ABC1 and related ABCA transporters: identification of N-linked glycosylation sites","volume":"276","author":"Bungert","year":"2001","journal-title":"J Biol Chem."},{"issue":"7","key":"10.1016\/j.bcp.2024.116468_b0155","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.cell.2017.05.020","article-title":"Structure of the Human Lipid Exporter ABCA1","volume":"169","author":"Qian","year":"2017","journal-title":"Cell."},{"issue":"2","key":"10.1016\/j.bcp.2024.116468_b0160","first-page":"259","article-title":"Characterization of the ABCA Transporter Subfamily: Identification of Prokaryotic and Eukaryotic Members","volume":"325","author":"Peelman","year":"2003","journal-title":"Phylogeny and Topology. J Mol Biol."},{"issue":"5","key":"10.1016\/j.bcp.2024.116468_b0165","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.bbadis.2006.01.011","article-title":"ABC A-subfamily transporters: Structure, function and disease","volume":"1762","author":"Kaminski","year":"2006","journal-title":"Biochim Biophys Acta."},{"issue":"3","key":"10.1016\/j.bcp.2024.116468_b0170","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/1479-7364-3-3-281","article-title":"Human ATP-binding cassette (ABC) transporter family","volume":"3","author":"Vasiliou","year":"2009","journal-title":"Hum Genomics."},{"issue":"9","key":"10.1016\/j.bcp.2024.116468_b0175","doi-asserted-by":"crossref","first-page":"5240","DOI":"10.1021\/acs.chemrev.0c00659","article-title":"Structure and Function of Hepatobiliary ATP Binding Cassette Transporters","volume":"121","author":"Kroll","year":"2021","journal-title":"Chem Rev."},{"issue":"1","key":"10.1016\/j.bcp.2024.116468_b0180","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/ncomms1927","article-title":"ABCA4 is an N-retinylidene-phosphatidylethanolamine and phosphatidylethanolamine importer","volume":"3","author":"Quazi","year":"2012","journal-title":"Nat Commun."},{"issue":"1","key":"10.1016\/j.bcp.2024.116468_b0185","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.bbrc.2004.01.044","article-title":"Sequence analysis of twin ATP binding cassette proteins involved in translational control, antibiotic resistance, and ribonuclease L inhibition","volume":"315","author":"Kerr","year":"2004","journal-title":"Biochem Biophys Res Commun."},{"issue":"9","key":"10.1016\/j.bcp.2024.116468_b0190","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.str.2018.05.019","article-title":"Crystal Structure of ATP-Bound Human ABCF1 Demonstrates a Unique Conformation of ABC Proteins","volume":"26","author":"Qu","year":"2018","journal-title":"Structure."},{"issue":"1","key":"10.1016\/j.bcp.2024.116468_b0195","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.virol.2007.10.012","article-title":"TULA proteins bind to ABCE-1, a host factor of HIV-1 assembly, and inhibit HIV-1 biogenesis in a UBA-dependent fashion","volume":"372","author":"Smirnova","year":"2008","journal-title":"Virology."},{"issue":"2","key":"10.1016\/j.bcp.2024.116468_b0200","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.tibs.2018.11.003","article-title":"Control of mRNA Translation by Versatile ATP-Driven Machines","volume":"44","author":"Gerovac","year":"2019","journal-title":"Trends Biochem Sci."},{"issue":"8","key":"10.1016\/j.bcp.2024.116468_b0205","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.resmic.2019.09.005","article-title":"ABC-F proteins in mRNA translation and antibiotic resistance","volume":"170","author":"Ousalem","year":"2019","journal-title":"Res Microbiol."},{"issue":"41","key":"10.1016\/j.bcp.2024.116468_b0210","doi-asserted-by":"crossref","first-page":"14937","DOI":"10.1074\/jbc.RA119.008477","article-title":"Biochemical characterization of the mouse ABCF3 protein, a partner of the flavivirus-resistance protein OAS1B","volume":"294","author":"Peterson","year":"2019","journal-title":"J Biol Chem."},{"issue":"2","key":"10.1016\/j.bcp.2024.116468_b0215","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/cam4.1964","article-title":"Association of ABC gene profiles with time to progression and resistance in ovarian cancer revealed by bioinformatics analyses","volume":"8","author":"Seborova","year":"2019","journal-title":"Cancer Med."},{"issue":"23","key":"10.1016\/j.bcp.2024.116468_b0220","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1002\/1873-3468.13921","article-title":"What monomeric nucleotide binding domains can teach us about dimeric ABC proteins","volume":"594","author":"Ford","year":"2020","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.bcp.2024.116468_b0225","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jhep.2007.08.015","article-title":"Association of the multidrug-resistance-associated protein gene (ABCC2) variants with intrahepatic cholestasis of pregnancy","volume":"48","author":"Sookoian","year":"2008","journal-title":"J Hepatol."},{"issue":"7","key":"10.1016\/j.bcp.2024.116468_b0230","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.3390\/ijms22073334","article-title":"Participation of ABCA1 Transporter in Pathogenesis of Chronic Obstructive Pulmonary Disease","volume":"22","author":"Kotlyarov","year":"2021","journal-title":"Int J Mol Sci."},{"issue":"5","key":"10.1016\/j.bcp.2024.116468_b0235","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00424-006-0109-y","article-title":"The apical conjugate efflux pump ABCC2 (MRP2)","volume":"453","author":"Nies","year":"2007","journal-title":"Pfl\u00fcg Arch - Eur J Physiol."},{"issue":"4922","key":"10.1016\/j.bcp.2024.116468_b0240","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1126\/science.2475911","article-title":"Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA","volume":"245","author":"Riordan","year":"1989","journal-title":"Science."},{"issue":"4922","key":"10.1016\/j.bcp.2024.116468_b0245","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1126\/science.2570460","article-title":"Identification of the cystic fibrosis gene: genetic analysis","volume":"245","author":"Kerem","year":"1989","journal-title":"Science."},{"issue":"4922","key":"10.1016\/j.bcp.2024.116468_b0250","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1126\/science.2772657","article-title":"Identification of the cystic fibrosis gene: chromosome walking and jumping","volume":"245","author":"Rommens","year":"1989","journal-title":"Science."},{"issue":"34","key":"10.1016\/j.bcp.2024.116468_b0255","doi-asserted-by":"crossref","first-page":"5073","DOI":"10.1021\/acs.biochem.8b00646","article-title":"R-Domain Phosphorylation by Protein Kinase A Stimulates Dissociation of Unhydrolyzed ATP from the First Nucleotide-Binding Site of the Cystic Fibrosis Transmembrane Conductance Regulator","volume":"57","author":"Aleksandrov","year":"2018","journal-title":"Biochemistry."},{"issue":"18","key":"10.1016\/j.bcp.2024.116468_b0260","doi-asserted-by":"crossref","first-page":"12742","DOI":"10.1016\/S0021-9258(18)42339-3","article-title":"Phosphorylation of the cystic fibrosis transmembrane conductance regulator","volume":"267","author":"Picciotto","year":"1992","journal-title":"J Biol Chem."},{"issue":"4","key":"10.1016\/j.bcp.2024.116468_b0265","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0092-8674(91)90072-7","article-title":"Nucleoside triphosphates are required to open the CFTR chloride channel","volume":"67","author":"Anderson","year":"1991","journal-title":"Cell."},{"issue":"4","key":"10.1016\/j.bcp.2024.116468_b0270","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/0092-8674(92)90155-6","article-title":"Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR)","volume":"68","author":"Bear","year":"1992","journal-title":"Cell."},{"issue":"19","key":"10.1016\/j.bcp.2024.116468_b0275","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1056\/NEJMra043184","article-title":"Cystic fibrosis","volume":"352","author":"Rowe","year":"2005","journal-title":"N Engl J Med."},{"issue":"35","key":"10.1016\/j.bcp.2024.116468_b0280","doi-asserted-by":"crossref","first-page":"5613","DOI":"10.1021\/bi501007v","article-title":"Cystic fibrosis transmembrane conductance regulator (CFTR) potentiators protect G551D but not \u0394F508 CFTR from thermal instability","volume":"53","author":"Liu","year":"2014","journal-title":"Biochemistry."},{"issue":"2","key":"10.1016\/j.bcp.2024.116468_b0285","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1172\/JCI115358","article-title":"Localization of the cystic fibrosis transmembrane conductance regulator in pancreas","volume":"88","author":"Marino","year":"1991","journal-title":"J Clin Invest."},{"issue":"1","key":"10.1016\/j.bcp.2024.116468_b0290","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/MPG.0b013e3181a6e01d","article-title":"Defining DIOS and constipation in cystic fibrosis with a multicentre study on the incidence, characteristics, and treatment of DIOS","volume":"50","author":"Houwen","year":"2010","journal-title":"J Pediatr Gastroenterol Nutr."},{"issue":"Pt 1","key":"10.1016\/j.bcp.2024.116468_b0295","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1113\/jphysiol.2005.099135","article-title":"Claudin-8 modulates paracellular permeability to acidic and basic ions in MDCK II cells","volume":"571","author":"Angelow","year":"2006","journal-title":"J Physiol."},{"issue":"24","key":"10.1016\/j.bcp.2024.116468_b0300","doi-asserted-by":"crossref","first-page":"13196","DOI":"10.3390\/ijms222413196","article-title":"Revisiting CFTR Interactions: Old Partners and New Players","volume":"22","author":"Farinha","year":"2021","journal-title":"Int J Mol Sci."},{"issue":"6","key":"10.1016\/j.bcp.2024.116468_b0305","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrm1949","article-title":"New insights into cystic fibrosis: molecular switches that regulate CFTR","volume":"7","author":"Guggino","year":"2006","journal-title":"Nat Rev Mol Cell Biol."},{"issue":"27","key":"10.1016\/j.bcp.2024.116468_b0310","doi-asserted-by":"crossref","first-page":"20653","DOI":"10.1016\/S0021-9258(20)80774-1","article-title":"Functional consequences of heterologous expression of the cystic fibrosis transmembrane conductance regulator in fibroblasts","volume":"268","author":"Stutts","year":"1993","journal-title":"J Biol Chem."},{"issue":"1","key":"10.1016\/j.bcp.2024.116468_b0315","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1513\/pats.2306015","article-title":"Submucosal glands and airway defense","volume":"1","author":"Wine","year":"2004","journal-title":"Proc Am Thorac Soc."},{"issue":"4","key":"10.1016\/j.bcp.2024.116468_b0320","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1152\/physrev.00004.2021","article-title":"Physiology and pathophysiology of human airway mucus","volume":"102","author":"Hill","year":"2022","journal-title":"Physiol Rev."},{"issue":"3","key":"10.1016\/j.bcp.2024.116468_b0325","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3390\/genes12030453","article-title":"Modulation of Ion Transport to Restore Airway Hydration in Cystic Fibrosis","volume":"12","author":"Reihill","year":"2021","journal-title":"Genes."},{"key":"10.1016\/j.bcp.2024.116468_b0330","unstructured":"Patient Registry | Cystic Fibrosis Foundation [Internet]. [cited 2023 Jul 3]. Available from: https:\/\/www.cff.org\/medical-professionals\/patient-registry."},{"key":"10.1016\/j.bcp.2024.116468_b0335","unstructured":"ECFS Patient Registry Annual Data Report 2018 | European Cystic Fibrosis Society (ECFS) [Internet]. [cited 2023 Jul 4]. Available from: https:\/\/www.ecfs.eu\/news\/ecfs-patient-registry-annual-data-report-2018."},{"issue":"10","key":"10.1016\/j.bcp.2024.116468_b0340","doi-asserted-by":"crossref","first-page":"5262","DOI":"10.3390\/ijms22105262","article-title":"Partial Rescue of F508del-CFTR Stability and Trafficking Defects by Double Corrector Treatment","volume":"22","author":"Capurro","year":"2021","journal-title":"Int J Mol Sci."},{"issue":"2","key":"10.1016\/j.bcp.2024.116468_b0345","doi-asserted-by":"crossref","first-page":"00716","DOI":"10.1183\/23120541.00716-2021","article-title":"Novel CFTR modulator combinations maximise rescue of G85E and N1303K in rectal organoids","volume":"8","author":"Ensinck","year":"2022","journal-title":"ERJ Open Res."},{"issue":"4","key":"10.1016\/j.bcp.2024.116468_b0350","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0092-8674(90)90148-8","article-title":"Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis","volume":"63","author":"Cheng","year":"1990","journal-title":"Cell."},{"issue":"6389","key":"10.1016\/j.bcp.2024.116468_b0355","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/358761a0","article-title":"Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive","volume":"358","author":"Denning","year":"1992","journal-title":"Nature."},{"issue":"6354","key":"10.1016\/j.bcp.2024.116468_b0360","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/354526a0","article-title":"Altered chloride ion channel kinetics associated with the delta F508 cystic fibrosis mutation","volume":"354","author":"Dalemans","year":"1991","journal-title":"Nature."},{"issue":"29","key":"10.1016\/j.bcp.2024.116468_b0365","doi-asserted-by":"crossref","first-page":"21592","DOI":"10.1016\/S0021-9258(20)80582-1","article-title":"The delta F508 mutation decreases the stability of cystic fibrosis transmembrane conductance regulator in the plasma membrane. Determination of functional half-lives on transfected cells","volume":"268","author":"Lukacs","year":"1993","journal-title":"J Biol Chem."},{"issue":"49","key":"10.1016\/j.bcp.2024.116468_b0370","doi-asserted-by":"crossref","first-page":"41937","DOI":"10.1074\/jbc.M111.296061","article-title":"Thermally unstable gating of the most common cystic fibrosis mutant channel (\u0394F508): \u201crescue\u201d by suppressor mutations in nucleotide binding domain 1 and by constitutive mutations in the cytosolic loops","volume":"286","author":"Wang","year":"2011","journal-title":"J Biol Chem."},{"issue":"9","key":"10.1016\/j.bcp.2024.116468_b0375","doi-asserted-by":"crossref","first-page":"13729","DOI":"10.1038\/s41598-019-50066-7","article-title":"Short-term consequences of F508del-CFTR thermal instability on CFTR-dependent transepithelial currents in human airway epithelial cells","volume":"24","author":"Froux","year":"2019","journal-title":"Sci Rep."},{"issue":"19","key":"10.1016\/j.bcp.2024.116468_b0380","doi-asserted-by":"crossref","first-page":"10282","DOI":"10.3390\/ijms221910282","article-title":"Structure-Based Understanding of ABCA3 Variants","volume":"22","author":"Onn\u00e9e","year":"2021","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.bcp.2024.116468_b0385","doi-asserted-by":"crossref","unstructured":"Xie T, Zhang Z, Yue J, Fang Q, Gong X. Cryo-EM structures of the human surfactant lipid transporter ABCA3. Sci Adv. 2022 Apr 8;8(14):eabn3727.","DOI":"10.1126\/sciadv.abn3727"},{"issue":"2","key":"10.1016\/j.bcp.2024.116468_b0390","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1006\/geno.1996.4500","article-title":"The Cloning of a Human ABC Gene (ABC3) Mapping to Chromosome 16p13.3","volume":"39","author":"Connors","year":"1997","journal-title":"Genomics."},{"issue":"1","key":"10.1016\/j.bcp.2024.116468_b0395","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1369\/jhc.6A6962.2006","article-title":"Expression of ABCA3 in Developing Lung and Other Tissues","volume":"55","author":"Stahlman","year":"2007","journal-title":"J Histochem Cytochem."},{"issue":"8","key":"10.1016\/j.bcp.2024.116468_b0400","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1194\/jlr.M013284","article-title":"A novel conserved targeting motif found in ABCA transporters mediates trafficking to early post-Golgi compartments","volume":"52","author":"Beers","year":"2011","journal-title":"J Lipid Res."},{"issue":"20","key":"10.1016\/j.bcp.2024.116468_b0405","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1016\/j.febslet.2010.09.026","article-title":"The surfactant lipid transporter ABCA3 is N-terminally cleaved inside LAMP3-positive vesicles","volume":"584","author":"Engelbrecht","year":"2010","journal-title":"FEBS Lett."},{"issue":"3","key":"10.1016\/j.bcp.2024.116468_b0410","doi-asserted-by":"crossref","first-page":"e0152594","DOI":"10.1371\/journal.pone.0152594","article-title":"Analysis of the Proteolytic Processing of ABCA3: Identification of Cleavage Site and Involved Proteases","volume":"11","author":"Hofmann","year":"2016","journal-title":"PLoS One."},{"issue":"291","key":"10.1016\/j.bcp.2024.116468_b0415","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jconrel.2018.10.012","article-title":"Pulmonary surfactant and drug delivery: Focusing on the role of surfactant proteins","volume":"10","author":"Guagliardo","year":"2018","journal-title":"J Controlled Release."},{"issue":"25","key":"10.1016\/j.bcp.2024.116468_b0420","doi-asserted-by":"crossref","first-page":"22147","DOI":"10.1074\/jbc.M201812200","article-title":"Identification of LBM180, a Lamellar Body Limiting Membrane Protein of Alveolar Type II Cells, as the ABC Transporter Protein ABCA3","volume":"277","author":"Mulugeta","year":"2002","journal-title":"J Biol Chem."},{"issue":"2","key":"10.1016\/j.bcp.2024.116468_b0425","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0014-5793(01)03056-3","article-title":"ABCA3 is a lamellar body membrane protein in human lung alveolar type II cells1","volume":"508","author":"Yamano","year":"2001","journal-title":"FEBS Lett."},{"issue":"209","key":"10.1016\/j.bcp.2024.116468_b0430","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.aanat.2016.09.008","article-title":"Pulmonary surfactant metabolism in the alveolar airspace: Biogenesis, extracellular conversions, recycling","volume":"1","author":"Olmeda","year":"2017","journal-title":"Ann Anat - Anat Anz."},{"issue":"5","key":"10.1016\/j.bcp.2024.116468_b0435","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1164\/rccm.200509-1535OC","article-title":"Alteration of the Pulmonary Surfactant System in Full-Term Infants with Hereditary ABCA3 Deficiency","volume":"174","author":"Brasch","year":"2006","journal-title":"Am J Respir Crit Care Med."},{"issue":"7","key":"10.1016\/j.bcp.2024.116468_b0440","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1172\/JCI0216452","article-title":"Consequences of cellular cholesterol accumulation: basic concepts and physiological implications","volume":"110","author":"Tabas","year":"2002","journal-title":"J Clin Invest."},{"issue":"7","key":"10.1016\/j.bcp.2024.116468_b0445","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.bbalip.2015.03.004","article-title":"ABCA3 protects alveolar epithelial cells against free cholesterol induced cell death","volume":"1851","author":"Zarbock","year":"2015","journal-title":"Biochim Biophys Acta."},{"issue":"13","key":"10.1016\/j.bcp.2024.116468_b0450","doi-asserted-by":"crossref","first-page":"9628","DOI":"10.1074\/jbc.M611767200","article-title":"ABCA3 as a Lipid Transporter in Pulmonary Surfactant Biogenesis","volume":"282","author":"Ban","year":"2007","journal-title":"J Biol Chem."},{"issue":"14","key":"10.1016\/j.bcp.2024.116468_b0455","doi-asserted-by":"crossref","first-page":"9791","DOI":"10.1074\/jbc.M507515200","article-title":"Functional and Trafficking Defects in ATP Binding Cassette A3 Mutants Associated with Respiratory Distress Syndrome","volume":"281","author":"Cheong","year":"2006","journal-title":"J Biol Chem."},{"issue":"13","key":"10.1016\/j.bcp.2024.116468_b0460","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa032178","article-title":"ABCA3 Gene Mutations in Newborns with Fatal Surfactant Deficiency","volume":"350","author":"Shulenin","year":"2004","journal-title":"N Engl J Med."},{"issue":"33","key":"10.1016\/j.bcp.2024.116468_b0465","doi-asserted-by":"crossref","first-page":"23811","DOI":"10.1074\/jbc.M703927200","article-title":"ABCA3 Is Critical for Lamellar Body Biogenesis in Vivo","volume":"282","author":"Cheong","year":"2007","journal-title":"J Biol Chem."},{"issue":"12","key":"10.1016\/j.bcp.2024.116468_b0470","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1164\/rccm.201402-0342OC","article-title":"Genotype-Phenotype Correlations for Infants and Children with ABCA3 Deficiency","volume":"189","author":"Wambach","year":"2014","journal-title":"Am J Respir Crit Care Med."},{"issue":"8","key":"10.1016\/j.bcp.2024.116468_b0475","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1164\/rccm.200503-504OC","article-title":"ABCA3 Mutations Associated with Pediatric Interstitial Lung Disease","volume":"172","author":"Bullard","year":"2005","journal-title":"Am J Respir Crit Care Med."},{"issue":"7","key":"10.1016\/j.bcp.2024.116468_b0480","doi-asserted-by":"crossref","first-page":"e00633","DOI":"10.1002\/rcr2.633","article-title":"ABCA3 deficiency from birth to adulthood presenting as paediatric interstitial lung disease","volume":"8","author":"Cho","year":"2020","journal-title":"Respirol Case Rep."},{"issue":"3","key":"10.1016\/j.bcp.2024.116468_b0485","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00066-2019","article-title":"Bi-allelic missense ABCA3 mutations in a patient with childhood ILD who reached adulthood","volume":"5","author":"Manali","year":"2019","journal-title":"ERJ Open Res."},{"issue":"3","key":"10.1016\/j.bcp.2024.116468_b0490","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/MCP.0000000000000680","article-title":"ABCA3 mutations in adult pulmonary fibrosis patients: a case series and review of literature","volume":"26","author":"Klay","year":"2020","journal-title":"Curr Opin Pulm Med."},{"issue":"3","key":"10.1016\/j.bcp.2024.116468_b0495","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1089\/ped.2022.0023","article-title":"Variable Expression of Lung Disease Due to a Novel Homozygous ABCA3 Variant","volume":"35","author":"Hamouda","year":"2022","journal-title":"Pediatr Allergy Immunol Pulmonol."},{"issue":"6","key":"10.1016\/j.bcp.2024.116468_b0500","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/thorax-2022-219434","article-title":"ABCA3-related interstitial lung disease beyond infancy","volume":"78","author":"Li","year":"2023","journal-title":"Thorax."},{"issue":"3","key":"10.1016\/j.bcp.2024.116468_b0505","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1136\/thoraxjnl-2016-208649","article-title":"Lung disease caused by ABCA3 mutations","volume":"72","author":"Kr\u00f6ner","year":"2017","journal-title":"Thorax."},{"issue":"1","key":"10.1016\/j.bcp.2024.116468_b0510","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1038\/s41598-020-58248-4","article-title":"In Vitro Functional and Structural Characterization of A Synthetic Clinical Pulmonary Surfactant with Enhanced Resistance to Inhibition","volume":"10","author":"Echaide","year":"2020","journal-title":"Sci Rep."},{"issue":"9","key":"10.1016\/j.bcp.2024.116468_b0515","doi-asserted-by":"crossref","first-page":"8179","DOI":"10.3390\/ijms24098179","article-title":"ABCA3 Deficiency\u2014Variant-Specific Response to Hydroxychloroquine","volume":"24","author":"Yang","year":"2023","journal-title":"Int J Mol Sci."},{"issue":"4","key":"10.1016\/j.bcp.2024.116468_b0520","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.chest.2022.11.002","article-title":"Progressive Disease With Low Survival in Adult Patients With Pulmonary Fibrosis Carrying Surfactant-Related Gene Mutations: An Observational Study","volume":"163","author":"Klay","year":"2023","journal-title":"Chest."},{"key":"10.1016\/j.bcp.2024.116468_b0525","doi-asserted-by":"crossref","DOI":"10.1016\/j.siny.2023.101500","article-title":"Towards personalized therapies for genetic disorders of surfactant dysfunction","author":"Peers de Nieuwburgh","year":"2023","journal-title":"Semin Fetal Neonatal Med."},{"issue":"184","key":"10.1016\/j.bcp.2024.116468_b0530","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jpeds.2017.01.017","article-title":"Outcomes of Lung Transplantation for Infants and Children with Genetic Disorders of Surfactant Metabolism","volume":"1","author":"Eldridge","year":"2017","journal-title":"J Pediatr."},{"issue":"3","key":"10.1016\/j.bcp.2024.116468_b0535","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/cphy.c120027","article-title":"Bile formation and secretion","volume":"3","author":"Boyer","year":"2013","journal-title":"Compr Physiol."},{"issue":"5","key":"10.1016\/j.bcp.2024.116468_b0540","first-page":"638","article-title":"Tissue distribution of the human MDR3 P-glycoprotein","volume":"71","author":"Smit","year":"1994","journal-title":"Lab Investig J Tech Methods Pathol."},{"issue":"1","key":"10.1016\/j.bcp.2024.116468_b0545","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41594-019-0354-3","article-title":"Structure of the human lipid exporter ABCB4 in a lipid environment","volume":"27","author":"Olsen","year":"2020","journal-title":"Nat Struct Mol Biol."},{"key":"10.1016\/j.bcp.2024.116468_b0550","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.pharmthera.2018.06.013","article-title":"Post-translational modifications of transporters","volume":"192","author":"Czuba","year":"2018","journal-title":"Pharmacol Ther."},{"issue":"11","key":"10.1016\/j.bcp.2024.116468_b0555","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1091\/mbc.7.11.1709","article-title":"Sequence requirements for membrane assembly of polytopic membrane proteins: molecular dissection of the membrane insertion process and topogenesis of the human MDR3 P-glycoprotein","volume":"7","author":"Zhang","year":"1996","journal-title":"Mol Biol Cell."},{"issue":"2","key":"10.1016\/j.bcp.2024.116468_b0560","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/hep.27170","article-title":"Phosphorylation of ABCB4 impacts its function: insights from disease-causing mutations","volume":"60","author":"Gautherot","year":"2014","journal-title":"Hepatology."},{"issue":"1","key":"10.1016\/j.bcp.2024.116468_b0565","doi-asserted-by":"crossref","first-page":"e0146962","DOI":"10.1371\/journal.pone.0146962","article-title":"A PDZ-Like Motif in the Biliary Transporter ABCB4 Interacts with the Scaffold Protein EBP50 and Regulates ABCB4 Cell Surface Expression","volume":"11","author":"Venot","year":"2016","journal-title":"PLoS One."},{"issue":"13","key":"10.1016\/j.bcp.2024.116468_b0570","doi-asserted-by":"crossref","first-page":"7087","DOI":"10.3390\/ijms22137087","article-title":"RAB10 Interacts with ABCB4 and Regulates Its Intracellular Traffic","volume":"22","author":"Ben Saad","year":"2021","journal-title":"Int J Mol Sci."},{"issue":"4","key":"10.1016\/j.bcp.2024.116468_b0575","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3390\/cells11040617","article-title":"MRCK-Alpha and Its Effector Myosin II Regulatory Light Chain Bind ABCB4 and Regulate Its Membrane Expression","volume":"11","author":"Bruneau","year":"2022","journal-title":"Cells."},{"issue":"3","key":"10.1016\/j.bcp.2024.116468_b0580","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0092-8674(00)81370-7","article-title":"MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine","volume":"87","author":"van Helvoort","year":"1996","journal-title":"Cell."},{"issue":"7","key":"10.1016\/j.bcp.2024.116468_b0585","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/0092-8674(94)90446-4","article-title":"Phosphatidylcholine translocase: a physiological role for the mdr2 gene","volume":"77","author":"Ruetz","year":"1994","journal-title":"Cell."},{"issue":"1","key":"10.1016\/j.bcp.2024.116468_b0590","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S1388-1981(00)00053-6","article-title":"ABC transporters in lipid transport","volume":"1486","author":"Borst","year":"2000","journal-title":"Biochim Biophys Acta."},{"issue":"10","key":"10.1016\/j.bcp.2024.116468_b0595","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.str.2021.05.013","article-title":"Evidence for a credit-card-swipe mechanism in the human PC floppase ABCB4","volume":"29","author":"Prescher","year":"2021","journal-title":"Structure."},{"issue":"33","key":"10.1016\/j.bcp.2024.116468_b0600","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2106702118","article-title":"Structures of ABCB4 provide insight into phosphatidylcholine translocation","volume":"118","author":"Nosol","year":"2021","journal-title":"Proc Natl Acad Sci."},{"issue":"2","key":"10.1016\/j.bcp.2024.116468_b0605","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/path.3019","article-title":"Canalicular ABC transporters and liver disease","volume":"226","author":"Nicolaou","year":"2012","journal-title":"J Pathol."},{"issue":"5","key":"10.1016\/j.bcp.2024.116468_b0610","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.clinre.2014.03.001","article-title":"ABCB4: Insights from pathobiology into therapy","volume":"38","author":"Falgui\u00e8res","year":"2014","journal-title":"Clin Res Hepatol Gastroenterol."},{"issue":"02","key":"10.1016\/j.bcp.2024.116468_b0615","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1055\/s-0030-1253223","article-title":"The Spectrum of Liver Diseases Related to ABCB4 Gene Mutations: Pathophysiology and Clinical Aspects","volume":"30","author":"Davit-Spraul","year":"2010","journal-title":"Semin Liver Dis."},{"key":"10.1016\/j.bcp.2024.116468_b0620","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2017.02.020","article-title":"Targeted pharmacotherapies for defective ABC transporters","volume":"136","author":"Vauthier","year":"2017","journal-title":"Biochem Pharmacol."},{"issue":"6","key":"10.1016\/j.bcp.2024.116468_b0625","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1053\/gast.2001.23984","article-title":"The wide spectrum of multidrug resistance 3 deficiency: From neonatal cholestasis to cirrhosis of adulthood","volume":"120","author":"Jacquemin","year":"2001","journal-title":"Gastroenterology."},{"key":"10.1016\/j.bcp.2024.116468_b0630","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/S2210-7401(12)70018-9","article-title":"Progressive familial intrahepatic cholestasis","volume":"36","author":"Jacquemin","year":"2012","journal-title":"Clin Res Hepatol Gastroenterol."},{"issue":"2","key":"10.1016\/j.bcp.2024.116468_b0635","article-title":"Low-phospholipid-associated cholelithiasis syndrome: Prevalence, clinical features, and comorbidities","volume":"3","author":"Dong","year":"2021","journal-title":"JHEP Rep."},{"issue":"2","key":"10.1016\/j.bcp.2024.116468_b0640","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.clinre.2015.12.008","article-title":"The pathophysiology of intrahepatic cholestasis of pregnancy","volume":"40","author":"Dixon","year":"2016","journal-title":"Clin Res Hepatol Gastroenterol."},{"issue":"01","key":"10.1016\/j.bcp.2024.116468_b0645","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1055\/s-0040-1722264","article-title":"Intrahepatic Cholestasis of Pregnancy: Natural History and Current Management","volume":"41","author":"Roediger","year":"2021","journal-title":"Semin Liver Dis."},{"issue":"4","key":"10.1016\/j.bcp.2024.116468_b0650","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/hep.22485","article-title":"A mutation in the canalicular phospholipid transporter gene, ABCB4, is associated with cholestasis, ductopenia, and cirrhosis in adults","volume":"48","author":"Gotthardt","year":"2008","journal-title":"Hepatology."},{"issue":"1","key":"10.1016\/j.bcp.2024.116468_b0655","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1053\/j.gastro.2008.03.044","article-title":"ABCB4 Heterozygous Gene Mutations Associated With Fibrosing Cholestatic Liver Disease in Adults","volume":"135","author":"Ziol","year":"2008","journal-title":"Gastroenterology."},{"issue":"3","key":"10.1016\/j.bcp.2024.116468_b0660","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.dld.2020.12.003","article-title":"ABCB4 variants in adult patients with cholestatic disease are frequent and underdiagnosed","volume":"53","author":"Avena","year":"2021","journal-title":"Dig Liver Dis."},{"issue":"16","key":"10.1016\/j.bcp.2024.116468_b0665","doi-asserted-by":"crossref","first-page":"10046","DOI":"10.1074\/jbc.273.16.10046","article-title":"The Sister of P-glycoprotein Represents the Canalicular Bile Salt Export Pump of Mammalian Liver","volume":"273","author":"Gerloff","year":"1998","journal-title":"J Biol Chem."},{"key":"10.1016\/j.bcp.2024.116468_b0670","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/978-3-642-14541-4_5","article-title":"The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation","volume":"201","author":"Stieger","year":"2011","journal-title":"Handb Exp Pharmacol."},{"issue":"7","key":"10.1016\/j.bcp.2024.116468_b0675","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/s41422-020-0302-0","article-title":"Cryo-EM structure of human bile salts exporter ABCB11","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"issue":"3","key":"10.1016\/j.bcp.2024.116468_b0680","doi-asserted-by":"crossref","first-page":"G818","DOI":"10.1152\/ajpgi.00415.2006","article-title":"Two N -linked glycans are required to maintain the transport activity of the bile salt export pump (ABCB11) in MDCK II cells","volume":"292","author":"Mochizuki","year":"2007","journal-title":"Am J Physiol-Gastrointest Liver Physiol."},{"key":"10.1016\/j.bcp.2024.116468_b0685","doi-asserted-by":"crossref","unstructured":"Morita S ya, Kobayashi A, Takanezawa Y, Kioka N, Handa T, Arai H, et al. Bile salt\u2013dependent efflux of cellular phospholipids mediated by ATP binding cassette protein B4. Hepatology. 2007 Jul;46(1):188\u201399.","DOI":"10.1002\/hep.21591"},{"issue":"5","key":"10.1016\/j.bcp.2024.116468_b0690","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41422-021-00611-9","article-title":"Structures of human bile acid exporter ABCB11 reveal a transport mechanism facilitated by two tandem substrate-binding pockets","volume":"32","author":"Wang","year":"2022","journal-title":"Cell Res."},{"key":"10.1016\/j.bcp.2024.116468_b0695","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.mam.2013.05.001","article-title":"Biosynthesis and trafficking of the bile salt export pump, BSEP: Therapeutic implications of BSEP mutations","volume":"37","author":"Soroka","year":"2014","journal-title":"Mol Aspects Med."},{"issue":"1","key":"10.1016\/j.bcp.2024.116468_b0700","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-4-1","article-title":"Progressive familial intrahepatic cholestasis","volume":"4","author":"Davit-Spraul","year":"2009","journal-title":"Orphanet J Rare Dis."},{"issue":"2","key":"10.1016\/j.bcp.2024.116468_b0705","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/hep.21287","article-title":"Hepatocellular carcinoma in ten children under five years of age with bile salt export pump deficiency","volume":"44","author":"Knisely","year":"2006","journal-title":"Hepatology."},{"issue":"5","key":"10.1016\/j.bcp.2024.116468_b0710","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jpeds.2007.02.030","article-title":"Mutations in Bile Salt Export Pump (ABCB11) in Two Children with Progressive Familial Intrahepatic Cholestasis and Cholangiocarcinoma","volume":"150","author":"Scheimann","year":"2007","journal-title":"J Pediatr."},{"issue":"2","key":"10.1016\/j.bcp.2024.116468_b0715","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1053\/j.gastro.2004.04.065","article-title":"Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11","volume":"127","author":"van Mil","year":"2004","journal-title":"Gastroenterology."},{"issue":"1","key":"10.1016\/j.bcp.2024.116468_b0720","doi-asserted-by":"crossref","first-page":"G58","DOI":"10.1152\/ajpgi.00367.2007","article-title":"Phenotypic differences in PFIC2 and BRIC2 correlate with protein stability of mutant Bsep and impaired taurocholate secretion in MDCK II cells","volume":"294","author":"Kagawa","year":"2008","journal-title":"Am J Physiol-Gastrointest Liver Physiol."},{"key":"10.1016\/j.bcp.2024.116468_b0725","doi-asserted-by":"crossref","DOI":"10.1177\/17562848231163410","article-title":"Drug-induced liver injury: a comprehensive review","volume":"16","author":"Hosack","year":"2023","journal-title":"Ther Adv Gastroenterol."},{"issue":"5","key":"10.1016\/j.bcp.2024.116468_b0730","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3748\/wjg.v23.i5.763","article-title":"Current and future therapies for inherited cholestatic liver diseases","volume":"23","author":"van der Woerd","year":"2017","journal-title":"World J Gastroenterol."},{"issue":"5","key":"10.1016\/j.bcp.2024.116468_b0735","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1002\/hep.23539","article-title":"ATP8B1 and ABCB11 analysis in 62 children with normal gamma-glutamyl transferase progressive familial intrahepatic cholestasis (PFIC): phenotypic differences between PFIC1 and PFIC2 and natural history","volume":"51","author":"Davit-Spraul","year":"2010","journal-title":"Hepatology."},{"issue":"9","key":"10.1016\/j.bcp.2024.116468_b0740","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1002\/hep4.1980","article-title":"Maralixibat for the treatment of PFIC: Long-term, IBAT inhibition in an open-label, Phase 2 study","volume":"6","author":"Loomes","year":"2022","journal-title":"Hepatol Commun."},{"issue":"9","key":"10.1016\/j.bcp.2024.116468_b0745","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S2468-1253(22)00093-0","article-title":"Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial","volume":"7","author":"Thompson","year":"2022","journal-title":"Lancet Gastroenterol Hepatol."},{"issue":"7","key":"10.1016\/j.bcp.2024.116468_b0750","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/0092-8674(93)90353-R","article-title":"Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis","volume":"73","author":"Welsh","year":"1993","journal-title":"Cell."},{"issue":"15","key":"10.1016\/j.bcp.2024.116468_b0755","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1056\/NEJM199410133311503","article-title":"A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations","volume":"331","author":"Highsmith","year":"1994","journal-title":"N Engl J Med."},{"issue":"8862","key":"10.1016\/j.bcp.2024.116468_b0760","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0140-6736(93)91885-P","article-title":"Mild cystic fibrosis and normal or borderline sweat test in patients with the 3849 + 10 kb C\u2013>T mutation","volume":"342","author":"Augarten","year":"1993","journal-title":"Lancet Lond Engl."},{"key":"10.1016\/j.bcp.2024.116468_b0765","doi-asserted-by":"crossref","unstructured":"Haardt M, Benharouga M, Lechardeur D, Kartner N, Lukacs GL. C-terminal truncations destabilize the cystic fibrosis transmembrane conductance regulator without impairing its biogenesis. A novel class of mutation. J Biol Chem. 1999 Jul 30;274(31):21873\u20137.","DOI":"10.1074\/jbc.274.31.21873"},{"issue":"8","key":"10.1016\/j.bcp.2024.116468_b0770","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S2213-2600(16)00023-0","article-title":"Progress in therapies for cystic fibrosis","volume":"4","author":"De Boeck","year":"2016","journal-title":"Lancet Respir Med."},{"issue":"14","key":"10.1016\/j.bcp.2024.116468_b0775","doi-asserted-by":"crossref","first-page":"e86581","DOI":"10.1172\/jci.insight.86581","article-title":"Analysis of cystic fibrosis-associated P67L CFTR illustrates barriers to personalized therapeutics for orphan diseases","volume":"1","author":"Sabusap","year":"2016","journal-title":"JCI Insight."},{"issue":"9","key":"10.1016\/j.bcp.2024.116468_b0780","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1113\/jphysiol.2014.271817","article-title":"Revertant mutants modify, but do not rescue, the gating defect of the cystic fibrosis mutant G551D-CFTR","volume":"592","author":"Xu","year":"2014","journal-title":"J Physiol."},{"issue":"12","key":"10.1016\/j.bcp.2024.116468_b0785","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1002\/ppul.23471","article-title":"Tools to explore ABCA3 mutations causing interstitial lung disease","volume":"51","author":"Wittmann","year":"2016","journal-title":"Pediatr Pulmonol."},{"key":"10.1016\/j.bcp.2024.116468_b0790","unstructured":"gnomAD [Internet]. [cited 2023 Jul 4]. Available from: https:\/\/gnomad.broadinstitute.org\/."},{"issue":"45","key":"10.1016\/j.bcp.2024.116468_b0795","doi-asserted-by":"crossref","first-page":"34503","DOI":"10.1074\/jbc.M600071200","article-title":"Characterization and Classification of ATP-binding Cassette Transporter ABCA3 Mutants in Fatal Surfactant Deficiency","volume":"281","author":"Matsumura","year":"2006","journal-title":"J Biol Chem."},{"issue":"5","key":"10.1016\/j.bcp.2024.116468_b0800","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1165\/rcmb.2021-0430LE","article-title":"Instability of Mature ABCA3 Protein: Toward a New Classification of ABCA3 Mutations?","volume":"67","author":"Onn\u00e9e","year":"2022","journal-title":"Am J Respir Cell Mol Biol."},{"issue":"6","key":"10.1016\/j.bcp.2024.116468_b0805","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/humu.23416","article-title":"ABCA3 missense mutations causing surfactant dysfunction disorders have distinct cellular phenotypes","volume":"39","author":"Schindlbeck","year":"2018","journal-title":"Hum Mutat."},{"issue":"8","key":"10.1016\/j.bcp.2024.116468_b0810","doi-asserted-by":"crossref","first-page":"7554","DOI":"10.3390\/ijms24087554","article-title":"Quantifying Functional Impairment of ABCA3 Variants Associated with Interstitial Lung Disease","volume":"24","author":"Yang","year":"2023","journal-title":"Int J Mol Sci."},{"issue":"6","key":"10.1016\/j.bcp.2024.116468_b0815","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/hmg\/ddy011","article-title":"Functional rescue of misfolding ABCA3 mutations by small molecular correctors","volume":"27","author":"Kinting","year":"2018","journal-title":"Hum Mol Genet."},{"issue":"8","key":"10.1016\/j.bcp.2024.116468_b0820","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1111\/jcmm.14397","article-title":"Potentiation of ABCA3 lipid transport function by ivacaftor and genistein","volume":"23","author":"Kinting","year":"2019","journal-title":"J Cell Mol Med."},{"key":"10.1016\/j.bcp.2024.116468_b0825","unstructured":"ABCMdb [Internet]. [cited 2023 Jul 4]. Available from: http:\/\/abcm2.hegelab.org\/."},{"key":"10.1016\/j.bcp.2024.116468_b0830","doi-asserted-by":"crossref","unstructured":"Bravo:Home [Internet]. [cited 2023 Dec 15]. Available from: https:\/\/bravobeta.sph.umich.edu\/.","DOI":"10.1504\/IJTEL.2023.127936"},{"issue":"4","key":"10.1016\/j.bcp.2024.116468_b0835","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1053\/j.gastro.2008.01.038","article-title":"Severe bile salt export pump deficiency: 82 different ABCB11 mutations in 109 families","volume":"134","author":"Strautnieks","year":"2008","journal-title":"Gastroenterology."},{"issue":"1","key":"10.1016\/j.bcp.2024.116468_b0840","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jhep.2020.02.007","article-title":"Genotype correlates with the natural history of severe bile salt export pump deficiency","volume":"73","author":"van Wessel","year":"2020","journal-title":"J Hepatol."},{"issue":"5","key":"10.1016\/j.bcp.2024.116468_b0845","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/hep.28300","article-title":"A functional classification of ABCB4 variations causing progressive familial intrahepatic cholestasis type 3","volume":"63","author":"Delaunay","year":"2016","journal-title":"Hepatology."},{"issue":"2","key":"10.1016\/j.bcp.2024.116468_b0850","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/hep.22683","article-title":"Missense mutations and single nucleotide polymorphisms in ABCB11 impair bile salt export pump processing and function or disrupt pre-messenger RNA splicing","volume":"49","author":"Byrne","year":"2009","journal-title":"Hepatology."},{"issue":"8","key":"10.1016\/j.bcp.2024.116468_b0855","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1016\/S2213-2600(16)30147-3","article-title":"Classification of CFTR mutation classes","volume":"4","author":"Stanke","year":"2016","journal-title":"Lancet Respir Med."},{"issue":"8","key":"10.1016\/j.bcp.2024.116468_b0860","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1016\/S2213-2600(16)30189-8","article-title":"Classification of CFTR mutation classes - Authors\u2019 reply","volume":"4","author":"De Boeck","year":"2016","journal-title":"Lancet Respir Med."},{"issue":"8","key":"10.1016\/j.bcp.2024.116468_b0865","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1016\/S2213-2600(16)30188-6","article-title":"Classification of CFTR mutation classes","volume":"4","author":"Marson","year":"2016","journal-title":"Lancet Respir Med."},{"issue":"32","key":"10.1016\/j.bcp.2024.116468_b0870","doi-asserted-by":"crossref","first-page":"19743","DOI":"10.1074\/jbc.M115.647685","article-title":"Rescuing Trafficking Mutants of the ATP-binding Cassette Protein, ABCA4, with Small Molecule Correctors as a Treatment for Stargardt Eye Disease","volume":"290","author":"Sabirzhanova","year":"2015","journal-title":"J Biol Chem."},{"issue":"8","key":"10.1016\/j.bcp.2024.116468_b0875","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1111\/liv.14518","article-title":"Functional rescue of an ABCB11 mutant by ivacaftor: A new targeted pharmacotherapy approach in bile salt export pump deficiency","volume":"40","author":"Mareux","year":"2020","journal-title":"Liver Int."},{"issue":"1","key":"10.1016\/j.bcp.2024.116468_b0880","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1186\/s13023-021-02125-4","article-title":"In vitro functional rescue by ivacaftor of an ABCB11 variant involved in PFIC2 and intrahepatic cholestasis of pregnancy","volume":"16","author":"Mareux","year":"2021","journal-title":"Orphanet J Rare Dis."},{"issue":"18","key":"10.1016\/j.bcp.2024.116468_b0885","doi-asserted-by":"crossref","first-page":"10758","DOI":"10.3390\/ijms231810758","article-title":"In Vitro Rescue of the Bile Acid Transport Function of ABCB11 Variants by CFTR Potentiators","volume":"23","author":"Mareux","year":"2022","journal-title":"Int J Mol Sci."},{"issue":"2","key":"10.1016\/j.bcp.2024.116468_b0890","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/hep.28929","article-title":"Functional defect of variants in the adenosine triphosphate\u2013binding sites of ABCB4 and their rescue by the cystic fibrosis transmembrane conductance regulator potentiator, ivacaftor (VX-770)","volume":"65","author":"Delaunay","year":"2017","journal-title":"Hepatology."},{"issue":"1","key":"10.1016\/j.bcp.2024.116468_b0895","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrg3849","article-title":"Cystic fibrosis genetics: from molecular understanding to clinical application","volume":"16","author":"Cutting","year":"2015","journal-title":"Nat Rev Genet."},{"key":"10.1016\/j.bcp.2024.116468_b0900","unstructured":"PolyPhen-2: prediction of functional effects of human nsSNPs [Internet]. [cited 2023 Jul 4]. Available from: http:\/\/genetics.bwh.harvard.edu\/pph2\/."},{"key":"10.1016\/j.bcp.2024.116468_b0905","unstructured":"SIFT - Predict effects of nonsynonmous \/ missense variants [Internet]. [cited 2023 Jul 4]. Available from: https:\/\/sift.bii.a-star.edu.sg\/."},{"key":"10.1016\/j.bcp.2024.116468_b0910","unstructured":"SNAP2 - Predicting functional effects of sequence variants [Internet]. [cited 2023 Jul 4]. Available from: https:\/\/rostlab.org\/services\/snap2web\/."},{"key":"10.1016\/j.bcp.2024.116468_b0915","unstructured":"J. Craig Venter Institute [Internet]. [cited 2023 Jul 4]. PROVEAN. Available from: https:\/\/www.jcvi.org\/research\/provean."},{"issue":"1","key":"10.1016\/j.bcp.2024.116468_b0920","first-page":"4","article-title":"Next-generation sequencing approach for the diagnosis of human diseases: open challenges and new opportunities","volume":"29","author":"Di Resta","year":"2018","journal-title":"EJIFCC."},{"issue":"5","key":"10.1016\/j.bcp.2024.116468_b0925","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med."},{"issue":"16","key":"10.1016\/j.bcp.2024.116468_b0930","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1093\/hmg\/ddx196","article-title":"Identification of the amino acids inserted during suppression of CFTR nonsense mutations and determination of their functional consequences","volume":"26","author":"Xue","year":"2017","journal-title":"Hum Mol Genet."},{"issue":"1","key":"10.1016\/j.bcp.2024.116468_b0935","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1741-7015-5-5","article-title":"In vitro prediction of stop-codon suppression by intravenous gentamicin in patients with cystic fibrosis: a pilot study","volume":"5","author":"Sermet-Gaudelus","year":"2007","journal-title":"BMC Med."},{"issue":"7","key":"10.1016\/j.bcp.2024.116468_b0940","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00109-006-0045-5","article-title":"Clinical doses of amikacin provide more effective suppression of the human CFTR-G542X stop mutation than gentamicin in a transgenic CF mouse model","volume":"84","author":"Du","year":"2006","journal-title":"J Mol Med."},{"issue":"13","key":"10.1016\/j.bcp.2024.116468_b0945","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1080\/14656566.2017.1359255","article-title":"Ataluren in cystic fibrosis: development, clinical studies and where are we now?","volume":"18","author":"Zainal Abidin","year":"2017","journal-title":"Expert Opin Pharmacother."},{"issue":"1","key":"10.1016\/j.bcp.2024.116468_b0950","doi-asserted-by":"crossref","first-page":"4358","DOI":"10.1038\/s41467-021-24575-x","article-title":"A small molecule that induces translational readthrough of CFTR nonsense mutations by eRF1 depletion","volume":"12","author":"Sharma","year":"2021","journal-title":"Nat Commun."},{"issue":"4","key":"10.1016\/j.bcp.2024.116468_b0955","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1002\/hep.31476","article-title":"Pharmacological Premature Termination Codon Readthrough of ABCB11 in Bile Salt Export Pump Deficiency: An In Vitro Study","volume":"73","author":"Amzal","year":"2021","journal-title":"Hepatology."},{"issue":"11","key":"10.1016\/j.bcp.2024.116468_b0960","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.dld.2022.04.002","article-title":"Antisense oligonucleotides rescue an intronic splicing variant in the ABCB11 gene that causes progressive familial intrahepatic cholestasis type 2","volume":"54","author":"Zheng","year":"2022","journal-title":"Dig Liver Dis."},{"issue":"3","key":"10.1016\/j.bcp.2024.116468_b0965","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2114858118","article-title":"Exon-skipping antisense oligonucleotides for cystic fibrosis therapy","volume":"119","author":"Kim","year":"2022","journal-title":"Proc Natl Acad Sci U S a."},{"issue":"4","key":"10.1016\/j.bcp.2024.116468_b0970","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.jcf.2021.12.012","article-title":"Antisense oligonucleotide splicing modulation as a novel Cystic Fibrosis therapeutic approach for the W1282X nonsense mutation","volume":"21","author":"Oren","year":"2022","journal-title":"J Cyst Fibros off J Eur Cyst Fibros Soc."},{"key":"10.1016\/j.bcp.2024.116468_b0975","unstructured":"Home | ClinicalTrials.gov [Internet]. [cited 2023 Dec 15]. Available from: https:\/\/www.clinicaltrials.gov\/."},{"issue":"9","key":"10.1016\/j.bcp.2024.116468_b0980","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/j.1398-9995.2011.02638.x","article-title":"Dose-response effects of TPI ASM8 in asthmatics after allergen","volume":"66","author":"Gauvreau","year":"2011","journal-title":"Allergy."},{"issue":"5","key":"10.1016\/j.bcp.2024.116468_b0985","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s11882-012-0290-3","article-title":"Therapeutic strategies for harnessing human eosinophils in allergic inflammation, hypereosinophilic disorders, and cancer","volume":"12","author":"Amini-Vaughan","year":"2012","journal-title":"Curr Allergy Asthma Rep."},{"issue":"3","key":"10.1016\/j.bcp.2024.116468_b0990","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1084\/jem.173.3.775","article-title":"Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5, and granulocyte\/macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects","volume":"173","author":"Kay","year":"1991","journal-title":"J Exp Med."},{"issue":"1","key":"10.1016\/j.bcp.2024.116468_b0995","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41572-019-0066-3","article-title":"Pulmonary alveolar proteinosis","volume":"5","author":"Trapnell","year":"2019","journal-title":"Nat Rev Dis Primer."},{"issue":"3","key":"10.1016\/j.bcp.2024.116468_b1000","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1042\/bj3140781","article-title":"Fibrates induce mdr2 gene expression and biliary phospholipid secretion in the mouse","volume":"314","author":"Chianale","year":"1996","journal-title":"Biochem J."},{"issue":"1","key":"10.1016\/j.bcp.2024.116468_b1005","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1006\/bbrc.2001.6141","article-title":"Fibrate and Statin Synergistically Increase the Transcriptional Activities of PPAR\u03b1\/RXR\u03b1 and Decrease the Transactivation of NF\u03baB","volume":"290","author":"Inoue","year":"2002","journal-title":"Biochem Biophys Res Commun."},{"issue":"1","key":"10.1016\/j.bcp.2024.116468_b1010","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1124\/mol.53.1.14","article-title":"Peroxisome Proliferator Activated Receptor-\u03b1 Expression in Human Liver","volume":"53","author":"Palmer","year":"1998","journal-title":"Mol Pharmacol."},{"issue":"10","key":"10.1016\/j.bcp.2024.116468_b1015","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1194\/jlr.M400132-JLR200","article-title":"Bezafibrate stimulates canalicular localization of NBD-labeled PC in HepG2 cells by PPAR\u03b1-mediated redistribution of ABCB4","volume":"45","author":"Shoda","year":"2004","journal-title":"J Lipid Res."},{"issue":"19","key":"10.1016\/j.bcp.2024.116468_b1020","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1091\/mbc.e13-05-0240","article-title":"VX-809 corrects folding defects in cystic fibrosis transmembrane conductance regulator protein through action on membrane-spanning domain 1","volume":"24","author":"Ren","year":"2013","journal-title":"Mol Biol Cell."},{"issue":"18","key":"10.1016\/j.bcp.2024.116468_b1025","doi-asserted-by":"crossref","first-page":"e139983","DOI":"10.1172\/jci.insight.139983","article-title":"Allosteric folding correction of F508del and rare CFTR mutants by elexacaftor-tezacaftor-ivacaftor (Trikafta) combination","volume":"5","author":"Veit","year":"2020","journal-title":"JCI Insight."},{"issue":"136","key":"10.1016\/j.bcp.2024.116468_b1030","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bcp.2017.03.020","article-title":"Corrector VX-809 promotes interactions between cytoplasmic loop one and the first nucleotide-binding domain of CFTR","volume":"15","author":"Loo","year":"2017","journal-title":"Biochem Pharmacol."},{"issue":"6617","key":"10.1016\/j.bcp.2024.116468_b1035","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1126\/science.ade2216","article-title":"Molecular structures reveal synergistic rescue of \u0394508 CFTR by Trikafta modulators","volume":"378","author":"Fiedorczuk","year":"2022","journal-title":"Science."},{"issue":"6","key":"10.1016\/j.bcp.2024.116468_b1040","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s10863-005-9499-3","article-title":"Rescue of Folding Defects in ABC Transporters Using Pharmacological Chaperones","volume":"37","author":"Loo","year":"2005","journal-title":"J Bioenerg Biomembr."},{"issue":"46","key":"10.1016\/j.bcp.2024.116468_b1045","doi-asserted-by":"crossref","first-page":"18843","DOI":"10.1073\/pnas.1105787108","article-title":"Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809","volume":"108","author":"Van Goor","year":"2011","journal-title":"Proc Natl Acad Sci U S a."},{"issue":"1","key":"10.1016\/j.bcp.2024.116468_b1050","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.cell.2021.12.009","article-title":"Mechanism of CFTR correction by type I folding correctors","volume":"185","author":"Fiedorczuk","year":"2022","journal-title":"Cell."},{"issue":"34","key":"10.1016\/j.bcp.2024.116468_b1055","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.coph.2017.09.018","article-title":"Transformative therapies for rare CFTR missense alleles","volume":"1","author":"Oliver","year":"2017","journal-title":"Curr Opin Pharmacol."},{"issue":"6","key":"10.1016\/j.bcp.2024.116468_b1060","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.jcf.2021.07.015","article-title":"Riociguat for the treatment of Phe508del homozygous adults with cystic fibrosis","volume":"20","author":"Derichs","year":"2021","journal-title":"J Cyst Fibros."},{"issue":"7","key":"10.1016\/j.bcp.2024.116468_b1065","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1074\/jbc.M111.275438","article-title":"Effects of Cellular, Chemical, and Pharmacological Chaperones on the Rescue of a Trafficking-defective Mutant of the ATP-binding Cassette Transporter Proteins ABCB1\/ABCB4","volume":"287","author":"Gautherot","year":"2012","journal-title":"J Biol Chem."},{"issue":"5","key":"10.1016\/j.bcp.2024.116468_b1070","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1002\/hep.26970","article-title":"Molecular mechanistic explanation for the spectrum of cholestatic disease caused by the S320F variant of ABCB4","volume":"59","author":"Andress","year":"2014","journal-title":"Hepatology."},{"issue":"6","key":"10.1016\/j.bcp.2024.116468_b1075","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/liv.14839","article-title":"Effect of CFTR correctors on the traffic and the function of intracellularly retained ABCB4 variants","volume":"41","author":"Ben Saad","year":"2021","journal-title":"Liver Int."},{"issue":"4","key":"10.1016\/j.bcp.2024.116468_b1080","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1165\/rcmb.2021-0223OC","article-title":"High-Content Screening Identifies Cyclosporin A as a Novel ABCA3-Specific Molecular Corrector","volume":"66","author":"Forstner","year":"2022","journal-title":"Am J Respir Cell Mol Biol."},{"key":"10.1016\/j.bcp.2024.116468_b1085","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.phrs.2013.11.009","article-title":"Defining the blanks \u2013 Pharmacochaperoning of SLC6 transporters and ABC transporters","volume":"83","author":"Chiba","year":"2014","journal-title":"Pharmacol Res."},{"issue":"11","key":"10.1016\/j.bcp.2024.116468_b1090","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.bbapap.2006.08.012","article-title":"Small molecule pharmacological chaperones: From thermodynamic stabilization to pharmaceutical drugs","volume":"1764","author":"Arakawa","year":"2006","journal-title":"Biochim Biophys Acta."},{"key":"10.1016\/j.bcp.2024.116468_b1095","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bcp.2017.03.020","article-title":"Corrector VX-809 promotes interactions between cytoplasmic loop one and the first nucleotide-binding domain of CFTR","volume":"136","author":"Loo","year":"2017","journal-title":"Biochem Pharmacol."},{"issue":"4","key":"10.1016\/j.bcp.2024.116468_b1100","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.ekir.2017.03.004","article-title":"The Chemical Chaperone, PBA, Reduces ER Stress and Autophagy and Increases Collagen IV \u03b15 Expression in Cultured Fibroblasts From Men With X-Linked Alport Syndrome and Missense Mutations","volume":"2","author":"Wang","year":"2017","journal-title":"Kidney Int Rep."},{"issue":"20","key":"10.1016\/j.bcp.2024.116468_b1105","doi-asserted-by":"crossref","first-page":"28849","DOI":"10.18632\/oncotarget.6680","article-title":"The histone deacetylase inhibitor SAHA induces HSP60 nitration and its extracellular release by exosomal vesicles in human lung-derived carcinoma cells","volume":"7","author":"Campanella","year":"2016","journal-title":"Oncotarget."},{"issue":"10","key":"10.1016\/j.bcp.2024.116468_b1110","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1172\/JCI119788","article-title":"In vitro pharmacologic restoration of CFTR-mediated chloride transport with sodium 4-phenylbutyrate in cystic fibrosis epithelial cells containing delta F508-CFTR","volume":"100","author":"Rubenstein","year":"1997","journal-title":"J Clin Invest."},{"issue":"2","key":"10.1016\/j.bcp.2024.116468_b1115","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1164\/ajrccm.157.2.9706088","article-title":"A pilot clinical trial of oral sodium 4-phenylbutyrate (Buphenyl) in deltaF508-homozygous cystic fibrosis patients: partial restoration of nasal epithelial CFTR function","volume":"157","author":"Rubenstein","year":"1998","journal-title":"Am J Respir Crit Care Med."},{"issue":"2","key":"10.1016\/j.bcp.2024.116468_b1120","doi-asserted-by":"crossref","first-page":"e0150098","DOI":"10.1371\/journal.pone.0150098","article-title":"Functional Rescue of Trafficking-Impaired ABCB4 Mutants by Chemical Chaperones","volume":"11","author":"Gordo-Gilart","year":"2016","journal-title":"PLoS One."},{"issue":"3","key":"10.1016\/j.bcp.2024.116468_b1125","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.jhep.2012.04.017","article-title":"Successful mutation-specific chaperone therapy with 4-phenylbutyrate in a child with progressive familial intrahepatic cholestasis type 2","volume":"57","author":"Gonzales","year":"2012","journal-title":"J Hepatol."},{"issue":"5","key":"10.1016\/j.bcp.2024.116468_b1130","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.jpeds.2013.12.032","article-title":"Improved Liver Function and Relieved Pruritus after 4-Phenylbutyrate Therapy in a Patient with Progressive Familial Intrahepatic Cholestasis Type 2","volume":"164","author":"Naoi","year":"2014","journal-title":"J Pediatr."},{"issue":"2","key":"10.1016\/j.bcp.2024.116468_b1135","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/hep.27767","article-title":"Targeted pharmacotherapy in progressive familial intrahepatic cholestasis type 2: Evidence for improvement of cholestasis with 4-phenylbutyrate","volume":"62","author":"Gonzales","year":"2015","journal-title":"Hepatology."},{"issue":"11","key":"10.1016\/j.bcp.2024.116468_b1140","doi-asserted-by":"crossref","first-page":"e1001998","DOI":"10.1371\/journal.pbio.1001998","article-title":"Modulation of the Maladaptive Stress Response to Manage Diseases of Protein Folding","volume":"12","author":"Roth","year":"2014","journal-title":"PLoS Biol."},{"issue":"3","key":"10.1016\/j.bcp.2024.116468_b1145","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.cbpa.2013.04.009","article-title":"Targeting unfolded protein response signaling pathways to ameliorate protein misfolding diseases","volume":"17","author":"Ryno","year":"2013","journal-title":"Curr Opin Chem Biol."},{"issue":"5","key":"10.1016\/j.bcp.2024.116468_b1150","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1600-0854.2006.00409.x","article-title":"Maintaining Low Ca2+ Level in the Endoplasmic Reticulum Restores Abnormal Endogenous F508del-CFTR Trafficking in Airway Epithelial Cells","volume":"7","author":"Norez","year":"2006","journal-title":"Traffic."},{"issue":"9","key":"10.1016\/j.bcp.2024.116468_b1155","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/cbic.200700027","article-title":"Correctors of Protein Trafficking Defects Identified by a Novel High-Throughput Screening Assay","volume":"8","author":"Carlile","year":"2007","journal-title":"ChemBioChem."},{"issue":"1","key":"10.1016\/j.bcp.2024.116468_b1160","doi-asserted-by":"crossref","first-page":"6653","DOI":"10.1038\/s41598-019-43111-y","article-title":"Structural analogues of roscovitine rescue the intracellular traffic and the function of ER-retained ABCB4 variants in cell models","volume":"9","author":"Vauthier","year":"2019","journal-title":"Sci Rep."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2024.116468_b1165","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1432-1033.1997.t01-2-00527.x","article-title":"Biochemical and Cellular Effects of Roscovitine, a Potent and Selective Inhibitor of the Cyclin-Dependent Kinases cdc2, cdk2 and cdk5","volume":"243","author":"Meijer","year":"1997","journal-title":"Eur J Biochem."},{"issue":"6","key":"10.1016\/j.bcp.2024.116468_b1170","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1021\/ar0201198","article-title":"Roscovitine and Other Purines as Kinase Inhibitors. From Starfish Oocytes to Clinical Trials","volume":"36","author":"Meijer","year":"2003","journal-title":"Acc Chem Res."},{"issue":"4","key":"10.1016\/j.bcp.2024.116468_b1175","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1159\/000444256","article-title":"Modulating Innate and Adaptive Immunity by (R)-Roscovitine: Potential Therapeutic Opportunity in Cystic Fibrosis","volume":"8","author":"Meijer","year":"2016","journal-title":"J Innate Immun."},{"issue":"21","key":"10.1016\/j.bcp.2024.116468_b1180","doi-asserted-by":"crossref","first-page":"4831","DOI":"10.1111\/bph.12859","article-title":"Roscovitine is a proteostasis regulator that corrects the trafficking defect of F508del-CFTR by a CDK-independent mechanism","volume":"171","author":"Norez","year":"2014","journal-title":"Br J Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2024.116468_b1185","doi-asserted-by":"crossref","first-page":"6653","DOI":"10.1038\/s41598-019-43111-y","article-title":"Structural analogues of roscovitine rescue the intracellular traffic and the function of ER-retained ABCB4 variants in cell models","volume":"9","author":"Vauthier","year":"2019","journal-title":"Sci Rep."},{"issue":"1","key":"10.1016\/j.bcp.2024.116468_b1190","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jcf.2014.06.001","article-title":"Ibuprofen rescues mutant cystic fibrosis transmembrane conductance regulator trafficking","volume":"14","author":"Carlile","year":"2015","journal-title":"J Cyst Fibros."},{"issue":"1","key":"10.1016\/j.bcp.2024.116468_b1195","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.1038\/s41598-022-08661-8","article-title":"The NSAID glafenine rescues class 2 CFTR mutants via cyclooxygenase 2 inhibition of the arachidonic acid pathway","volume":"12","author":"Carlile","year":"2022","journal-title":"Sci Rep."},{"issue":"8733","key":"10.1016\/j.bcp.2024.116468_b1200","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/0140-6736(91)90751-A","article-title":"Withdrawal of glafenine","volume":"337","author":"Belgium","year":"1991","journal-title":"The Lancet."},{"issue":"sup204","key":"10.1016\/j.bcp.2024.116468_b1205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/00365529409103618","article-title":"Pharmacology of Ursodeoxycholic Acid, an Enterohepatic Drug","volume":"29","author":"Hofmann","year":"1994","journal-title":"Scand J Gastroenterol."},{"key":"10.1016\/j.bcp.2024.116468_b1210","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S2210-7401(12)70015-3","article-title":"Ursodeoxycholic acid and bile-acid mimetics as therapeutic agents for cholestatic liver diseases: An overview of their mechanisms of action","volume":"36","author":"Poupon","year":"2012","journal-title":"Clin Res Hepatol Gastroenterol."},{"issue":"4","key":"10.1016\/j.bcp.2024.116468_b1215","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1053\/gast.1997.v113.pm9322526","article-title":"Mitogen-activated protein kinases mediate the stimulation of bile acid secretion by tauroursodeoxycholate in rat liver","volume":"113","author":"Schliess","year":"1997","journal-title":"Gastroenterology."},{"issue":"2","key":"10.1016\/j.bcp.2024.116468_b1220","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1053\/gast.2001.26262","article-title":"Tauroursodesoxycholate-induced choleresis involves p38MAPK activation and translocation of the bile salt export pump in rats","volume":"121","author":"Kurz","year":"2001","journal-title":"Gastroenterology."},{"issue":"5","key":"10.1016\/j.bcp.2024.116468_b1225","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1053\/jhep.2001.24034","article-title":"Tauroursodeoxycholic acid inserts the apical conjugate export pump, Mrp2, into canalicular membranes and stimulates organic anion secretion by protein kinase C\u2013dependent mechanisms in cholestatic rat liver","volume":"33","author":"Beuers","year":"2001","journal-title":"Hepatology."},{"issue":"5","key":"10.1016\/j.bcp.2024.116468_b1230","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/S0016-5085(03)00274-9","article-title":"Involvement of integrins and Src in tauroursodeoxycholate-induced and swelling-induced choleresis","volume":"124","author":"H\u00e4ussinger","year":"2003","journal-title":"Gastroenterology."},{"issue":"3","key":"10.1016\/j.bcp.2024.116468_b1235","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jhep.2020.04.036","article-title":"Variants in ABCB4 (MDR3) across the spectrum of cholestatic liver diseases in adults","volume":"73","author":"St\u00e4ttermayer","year":"2020","journal-title":"J Hepatol."},{"issue":"1","key":"10.1016\/j.bcp.2024.116468_b1240","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0168-8278(03)00483-5","article-title":"A progressive familial intrahepatic cholestasis type 2 mutation causes an unstable, temperature-sensitive bile salt export pump","volume":"40","author":"Plass","year":"2004","journal-title":"J Hepatol."},{"issue":"5","key":"10.1016\/j.bcp.2024.116468_b1245","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1002\/hep.22499","article-title":"Degradation of the bile salt export pump at endoplasmic reticulum in progressive familial intrahepatic cholestasis type II","volume":"48","author":"Wang","year":"2008","journal-title":"Hepatology."},{"issue":"4","key":"10.1016\/j.bcp.2024.116468_b1250","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/hep.22775","article-title":"A missense mutation in ABCB4 gene involved in progressive familial intrahepatic cholestasis type 3 leads to a folding defect that can be rescued by low temperature","volume":"49","author":"Delaunay","year":"2009","journal-title":"Hepatology."},{"issue":"6446","key":"10.1016\/j.bcp.2024.116468_b1255","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1126\/science.aaw7611","article-title":"Structural identification of a hotspot on CFTR for potentiation","volume":"364","author":"Liu","year":"2019","journal-title":"Science."},{"issue":"3","key":"10.1016\/j.bcp.2024.116468_b1260","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/MOP.0000000000000627","article-title":"Cystic fibrosis transmembrane conductance regulator modulators: precision medicine in cystic fibrosis","volume":"30","author":"Burgener","year":"2018","journal-title":"Curr Opin Pediatr."},{"issue":"2","key":"10.1016\/j.bcp.2024.116468_b1265","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/hep.28929","article-title":"Functional defect of variants in the adenosine triphosphate\u2013binding sites of ABCB4 and their rescue by the cystic fibrosis transmembrane conductance regulator potentiator, ivacaftor (VX-770)","volume":"65","author":"Delaunay","year":"2017","journal-title":"Hepatology."},{"issue":"2","key":"10.1016\/j.bcp.2024.116468_b1270","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.3390\/ijms24021236","article-title":"Ivacaftor-Mediated Potentiation of ABCB4 Missense Mutations Affecting Critical Motifs of the NBDs: Repositioning Perspectives for Hepatobiliary Diseases","volume":"24","author":"Delaunay","year":"2023","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.bcp.2024.116468_b1275","doi-asserted-by":"crossref","unstructured":"Laselva O, Qureshi Z, Zeng ZW, Petrotchenko EV, Ramjeesingh M, Hamilton CM, et al. Identification of binding sites for ivacaftor on the cystic fibrosis transmembrane conductance regulator. iScience. 2021 Jun 25;24(6):102542.","DOI":"10.1016\/j.isci.2021.102542"},{"issue":"12","key":"10.1016\/j.bcp.2024.116468_b1280","doi-asserted-by":"crossref","first-page":"923","DOI":"10.3390\/membranes11120923","article-title":"Structure of ABCB1\/P-Glycoprotein in the Presence of the CFTR Potentiator Ivacaftor","volume":"11","author":"Barbieri","year":"2021","journal-title":"Membranes."},{"issue":"44","key":"10.1016\/j.bcp.2024.116468_b1285","doi-asserted-by":"crossref","first-page":"36639","DOI":"10.1074\/jbc.M112.393637","article-title":"Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Potentiator VX-770 (Ivacaftor) Opens the Defective Channel Gate of Mutant CFTR in a Phosphorylation-dependent but ATP-independent Manner","volume":"287","author":"Eckford","year":"2012","journal-title":"J Biol Chem."},{"issue":"7","key":"10.1016\/j.bcp.2024.116468_b1290","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1085\/jgp.201912360","article-title":"Identifying the molecular target sites for CFTR potentiators GLPG1837 and VX-770","volume":"151","author":"Yeh","year":"2019","journal-title":"J Gen Physiol."},{"issue":"1","key":"10.1016\/j.bcp.2024.116468_b1295","doi-asserted-by":"crossref","first-page":"17640","DOI":"10.1038\/s41598-019-54158-2","article-title":"Nanomolar-potency \u2018co-potentiator\u2019 therapy for cystic fibrosis caused by a defined subset of minimal function CFTR mutants","volume":"9","author":"Phuan","year":"2019","journal-title":"Sci Rep."},{"issue":"5","key":"10.1016\/j.bcp.2024.116468_b1300","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jcf.2018.05.010","article-title":"Combination potentiator (\u2018co-potentiator\u2019) therapy for CF caused by CFTR mutants, including N1303K, that are poorly responsive to single potentiators","volume":"17","author":"Phuan","year":"2018","journal-title":"J Cyst Fibros."},{"issue":"18","key":"10.1016\/j.bcp.2024.116468_b1305","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1016\/j.febslet.2005.06.026","article-title":"A quantitative description of the activation and inhibition of CFTR by potentiators: Genistein","volume":"579","author":"Moran","year":"2005","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.bcp.2024.116468_b1310","doi-asserted-by":"crossref","first-page":"19810","DOI":"10.1038\/s41598-021-99184-1","article-title":"Elexacaftor is a CFTR potentiator and acts synergistically with ivacaftor during acute and chronic treatment","volume":"11","author":"Shaughnessy","year":"2021","journal-title":"Sci Rep."},{"issue":"5","key":"10.1016\/j.bcp.2024.116468_b1315","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jcf.2021.03.011","article-title":"Elexacaftor co-potentiates the activity of F508del and gating mutants of CFTR","volume":"20","author":"Veit","year":"2021","journal-title":"J Cyst Fibros."},{"issue":"1","key":"10.1016\/j.bcp.2024.116468_b1320","doi-asserted-by":"crossref","first-page":"19810","DOI":"10.1038\/s41598-021-99184-1","article-title":"Elexacaftor is a CFTR potentiator and acts synergistically with ivacaftor during acute and chronic treatment","volume":"11","author":"Shaughnessy","year":"2021","journal-title":"Sci Rep."},{"issue":"3","key":"10.1016\/j.bcp.2024.116468_b1325","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1091\/mbc.e14-04-0935","article-title":"From CFTR biology toward combinatorial pharmacotherapy: expanded classification of cystic fibrosis mutations","volume":"27","author":"Veit","year":"2016","journal-title":"Mol Biol Cell."},{"issue":"17","key":"10.1016\/j.bcp.2024.116468_b1330","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1056\/NEJMoa1807120","article-title":"VX-445\u2013Tezacaftor\u2013Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles","volume":"379","author":"Keating","year":"2018","journal-title":"N Engl J Med."},{"issue":"2","key":"10.1016\/j.bcp.2024.116468_b1335","doi-asserted-by":"crossref","first-page":"2100671","DOI":"10.1183\/13993003.00671-2021","article-title":"The rescue of F508del-CFTR by elexacaftor\/tezacaftor\/ivacaftor (Trikafta) in human airway epithelial cells is underestimated due to the presence of ivacaftor","volume":"59","author":"Becq","year":"2022","journal-title":"Eur Respir J."},{"issue":"3","key":"10.1016\/j.bcp.2024.116468_b1340","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1124\/pr.59.3.2","article-title":"G protein-coupled receptor trafficking in health and disease: lessons learned to prepare for therapeutic mutant rescue in vivo","volume":"59","author":"Conn","year":"2007","journal-title":"Pharmacol Rev."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224004519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224004519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T17:16:22Z","timestamp":1741713382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295224004519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":268,"alternative-id":["S0006295224004519"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116468","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ABC transporters involved in respiratory and cholestatic diseases: From rare to very rare monogenic diseases","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116468","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116468"}}